Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.

Henriksen EK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E.

J Hepatol. 2017 Jan;66(1):116-122. doi: 10.1016/j.jhep.2016.09.002. Epub 2016 Sep 17.

PMID:
27647428
2.

Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.

Lorentzen JA, Grzyb K, De Angelis PM, Hoff G, Eide TJ, Andresen PA.

Clin Med Insights Pathol. 2016 Sep 7;9:19-28. doi: 10.4137/CPath.s40143. eCollection 2016.

3.

A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency.

Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B.

Am J Gastroenterol. 2016 Oct;111(10):1467-1475. doi: 10.1038/ajg.2016.329. Epub 2016 Aug 16.

PMID:
27527747
4.

Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.

Labori KJ, Katz MH, Tzeng CW, Bjørnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP.

Acta Oncol. 2016;55(3):265-77. doi: 10.3109/0284186X.2015.1068445. Epub 2015 Jul 25.

PMID:
26213211
5.

The biliary epithelium presents antigens to and activates natural killer T cells.

Schrumpf E, Tan C, Karlsen TH, Sponheim J, Björkström NK, Sundnes O, Alfsnes K, Kaser A, Jefferson DM, Ueno Y, Eide TJ, Haraldsen G, Zeissig S, Exley MA, Blumberg RS, Melum E.

Hepatology. 2015 Oct;62(4):1249-59. doi: 10.1002/hep.27840. Epub 2015 May 20.

6.

Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.

Sandhu V, Bowitz Lothe IM, Labori KJ, Lingjærde OC, Buanes T, Dalsgaard AM, Skrede ML, Hamfjord J, Haaland T, Eide TJ, Børresen-Dale AL, Ikdahl T, Kure EH.

Mol Oncol. 2015 Apr;9(4):758-71. doi: 10.1016/j.molonc.2014.12.002. Epub 2014 Dec 19.

7.

Long-term risk of colorectal cancer in individuals with serrated polyps.

Holme Ø, Bretthauer M, Eide TJ, Løberg EM, Grzyb K, Løberg M, Kalager M, Adami HO, Kjellevold Ø, Hoff G.

Gut. 2015 Jun;64(6):929-36. doi: 10.1136/gutjnl-2014-307793. Epub 2014 Nov 16.

PMID:
25399542
8.

Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions.

Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Øyen O.

Am J Transplant. 2015 Jan;15(1):242-50. doi: 10.1111/ajt.12953. Epub 2014 Nov 13.

9.

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Schneede J, Tveit KM, Hoff G.

JAMA. 2014 Aug 13;312(6):606-15. doi: 10.1001/jama.2014.8266. Erratum in: JAMA. 2014 Sep 3;312(9):964.

10.

[Consensus-based guidelines may prevent necessary research].

Hoff G, Bretthauer M, Garborg K, Eide TJ.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):148-9. doi: 10.4045/tidsskr.13.1313. Norwegian. No abstract available.

11.

New polyps, old tricks: controversy about removing benign bowel lesions.

Hoff G, Bretthauer M, Garborg K, Eide TJ.

BMJ. 2013 Oct 8;347:f5843. doi: 10.1136/bmj.f5843. Review. No abstract available.

PMID:
24103540
12.

Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.

Kielland KB, Delaveris GJ, Rogde S, Eide TJ, Amundsen EJ, Dalgard O.

J Hepatol. 2014 Feb;60(2):260-6. doi: 10.1016/j.jhep.2013.09.022. Epub 2013 Oct 2.

PMID:
24096048
13.

A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.

Waaler J, Machon O, Tumova L, Dinh H, Korinek V, Wilson SR, Paulsen JE, Pedersen NM, Eide TJ, Machonova O, Gradl D, Voronkov A, von Kries JP, Krauss S.

Cancer Res. 2012 Jun 1;72(11):2822-32. doi: 10.1158/0008-5472.CAN-11-3336. Epub 2012 Mar 22.

14.

Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.

Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K.

Neuro Oncol. 2011 Nov;13(11):1225-33. doi: 10.1093/neuonc/nor114. Epub 2011 Aug 19.

15.

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

Fluge Ø, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, Otte AP, Akslen LA, Dahl O; Norwegian Gastrointestinal Cancer Group.

Br J Cancer. 2009 Oct 20;101(8):1282-9. doi: 10.1038/sj.bjc.6605333. Epub 2009 Sep 22.

16.

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.

Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group.

BMJ. 2009 May 29;338:b1846. doi: 10.1136/bmj.b1846.

17.

APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T Jr.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1463-70. doi: 10.1007/s00432-009-0594-4. Epub 2009 May 15. Erratum in: J Cancer Res Clin Oncol. 2009 Oct;135(10):1471. Eklo, Kristin [corrected to Eklo, Katrine].

PMID:
19444466
18.

Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma.

Westgaard A, Larønningen S, Mellem C, Eide TJ, Clausen OP, Møller B, Gladhaug IP.

Eur J Cancer. 2009 Nov;45(16):2850-9. doi: 10.1016/j.ejca.2009.03.019. Epub 2009 Apr 17.

PMID:
19376696
19.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
20.

Gastrointestinal stromal tumors (GISTs): a review.

Steigen SE, Eide TJ.

APMIS. 2009 Feb;117(2):73-86. doi: 10.1111/j.1600-0463.2008.00020.x. Review.

PMID:
19239429

Supplemental Content

Loading ...
Support Center